UniProt ID | ESCO1_HUMAN | |
---|---|---|
UniProt AC | Q5FWF5 | |
Protein Name | N-acetyltransferase ESCO1 | |
Gene Name | ESCO1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 840 | |
Subcellular Localization | Nucleus . Chromosome . Nuclear at interphase, associated with chromosomes during mitosis. | |
Protein Description | Acetyltransferase required for the establishment of sister chromatid cohesion. [PubMed: 15958495] | |
Protein Sequence | MMSIQEKSKENSSKVTKKSDDKNSETEIQDSQKNLAKKSGPKETIKSQAKSSSESKINQPELETRMSTRSSKAASNDKATKSINKNTVTVRGYSQESTKKKLSQKKLVHENPKANEQLNRRSQRLQQLTEVSRRSLRSREIQGQVQAVKQSLPPTKKEQCSSTQSKSNKTSQKHVKRKVLEVKSDSKEDENLVINEVINSPKGKKRKVEHQTACACSSQCTQGSEKCPQKTTRRDETKPVPVTSEVKRSKMATSVVPKKNEMKKSVHTQVNTNTTLPKSPQPSVPEQSDNELEQAGKSKRGSILQLCEEIAGEIESDNVEVKKESSQMESVKEEKPTEIKLEETSVERQILHQKETNQDVQCNRFFPSRKTKPVKCILNGINSSAKKNSNWTKIKLSKFNSVQHNKLDSQVSPKLGLLRTSFSPPALEMHHPVTQSTFLGTKLHDRNITCQQEKMKEINSEEVKINDITVEINKTTERAPENCHLANEIKPSDPPLDNQMKHSFDSASNKNFSQCLESKLENSPVENVTAASTLLSQAKIDTGENKFPGSAPQQHSILSNQTSKSSDNRETPRNHSLPKCNSHLEITIPKDLKLKEAEKTDEKQLIIDAGQKRFGAVSCNVCGMLYTASNPEDETQHLLFHNQFISAVKYVGWKKERILAEYPDGRIIMVLPEDPKYALKKVDEIREMVDNDLGFQQAPLMCYSRTKTLLFISNDKKVVGCLIAEHIQWGYRVIEEKLPVIRSEEEKVRFERQKAWCCSTLPEPAICGISRIWVFSMMRRKKIASRMIECLRSNFIYGSYLSKEEIAFSDPTPDGKLFATQYCGTGQFLVYNFINGQNST | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MMSIQEKSKE -----CCCHHHHCCC | 21.59 | 23401153 | |
8 | Phosphorylation | MMSIQEKSKENSSKV CCCHHHHCCCCCCCC | 44.44 | 23401153 | |
9 | Acetylation | MSIQEKSKENSSKVT CCHHHHCCCCCCCCC | 72.48 | 7695277 | |
17 | Acetylation | ENSSKVTKKSDDKNS CCCCCCCCCCCCCCC | 53.95 | 7695287 | |
24 | Phosphorylation | KKSDDKNSETEIQDS CCCCCCCCHHHHHHH | 52.19 | 25159151 | |
26 | Phosphorylation | SDDKNSETEIQDSQK CCCCCCHHHHHHHHH | 37.90 | 28985074 | |
31 | Phosphorylation | SETEIQDSQKNLAKK CHHHHHHHHHHHHHH | 27.03 | 17525332 | |
33 | Acetylation | TEIQDSQKNLAKKSG HHHHHHHHHHHHHHC | 58.86 | 26051181 | |
53 | Phosphorylation | KSQAKSSSESKINQP HHHHHCCCCCCCCCH | 53.64 | 22468782 | |
55 | Phosphorylation | QAKSSSESKINQPEL HHHCCCCCCCCCHHH | 40.56 | 22468782 | |
55 | O-linked_Glycosylation | QAKSSSESKINQPEL HHHCCCCCCCCCHHH | 40.56 | 30379171 | |
56 | Ubiquitination | AKSSSESKINQPELE HHCCCCCCCCCHHHH | 41.44 | - | |
68 | Phosphorylation | ELETRMSTRSSKAAS HHHHHHHHHCHHHHC | 25.81 | - | |
70 | Phosphorylation | ETRMSTRSSKAASND HHHHHHHCHHHHCCC | 35.96 | - | |
71 | Phosphorylation | TRMSTRSSKAASNDK HHHHHHCHHHHCCCC | 24.03 | 22210691 | |
75 | Phosphorylation | TRSSKAASNDKATKS HHCHHHHCCCCCCHH | 50.88 | 22210691 | |
89 | Phosphorylation | SINKNTVTVRGYSQE HHCCCCEEEEEECHH | 11.49 | - | |
135 | Phosphorylation | LTEVSRRSLRSREIQ HHHHHHHHHHHHHHH | 27.33 | 20068231 | |
138 | Phosphorylation | VSRRSLRSREIQGQV HHHHHHHHHHHHHHH | 39.29 | 20068231 | |
151 | Phosphorylation | QVQAVKQSLPPTKKE HHHHHHHCCCCCCHH | 36.81 | 18452278 | |
161 | Phosphorylation | PTKKEQCSSTQSKSN CCCHHHCCCCCCCCC | 35.79 | 25627689 | |
162 | Phosphorylation | TKKEQCSSTQSKSNK CCHHHCCCCCCCCCH | 37.78 | 25627689 | |
163 | Phosphorylation | KKEQCSSTQSKSNKT CHHHCCCCCCCCCHH | 22.14 | 25627689 | |
165 | Phosphorylation | EQCSSTQSKSNKTSQ HHCCCCCCCCCHHHH | 37.83 | 25627689 | |
170 | O-linked_Glycosylation | TQSKSNKTSQKHVKR CCCCCCHHHHHHHHH | 40.41 | 30379171 | |
184 | Phosphorylation | RKVLEVKSDSKEDEN HHEEEECCCCCCCCC | 52.90 | 25072903 | |
186 | Phosphorylation | VLEVKSDSKEDENLV EEEECCCCCCCCCCH | 45.06 | 25072903 | |
200 | Phosphorylation | VINEVINSPKGKKRK HHHHHHCCCCCCCCC | 19.50 | 30266825 | |
218 | Phosphorylation | QTACACSSQCTQGSE CEECHHCHHCCCCCC | 29.20 | - | |
243 | Phosphorylation | ETKPVPVTSEVKRSK CCCCCCCCHHHHHHH | 17.07 | 28555341 | |
265 | Phosphorylation | KKNEMKKSVHTQVNT CCCCCCCCEEEEECC | 17.39 | 22468782 | |
268 | Phosphorylation | EMKKSVHTQVNTNTT CCCCCEEEEECCCCC | 31.86 | 29978859 | |
268 | O-linked_Glycosylation | EMKKSVHTQVNTNTT CCCCCEEEEECCCCC | 31.86 | 30379171 | |
272 | Phosphorylation | SVHTQVNTNTTLPKS CEEEEECCCCCCCCC | 34.78 | 29978859 | |
274 | Phosphorylation | HTQVNTNTTLPKSPQ EEEECCCCCCCCCCC | 27.89 | 29978859 | |
275 | Phosphorylation | TQVNTNTTLPKSPQP EEECCCCCCCCCCCC | 43.03 | 29978859 | |
279 | Phosphorylation | TNTTLPKSPQPSVPE CCCCCCCCCCCCCCC | 27.16 | 30266825 | |
283 | Phosphorylation | LPKSPQPSVPEQSDN CCCCCCCCCCCCCHH | 45.09 | 30266825 | |
288 | Phosphorylation | QPSVPEQSDNELEQA CCCCCCCCHHHHHHH | 40.52 | 25262027 | |
297 | Acetylation | NELEQAGKSKRGSIL HHHHHHHHCCCHHHH | 56.68 | 25953088 | |
332 | Sumoylation | SSQMESVKEEKPTEI HHHCCHHCCCCCCCC | 70.23 | 25772364 | |
344 | Phosphorylation | TEIKLEETSVERQIL CCCCCCCHHHHHHHH | 28.79 | 29449344 | |
345 | Phosphorylation | EIKLEETSVERQILH CCCCCCHHHHHHHHH | 25.84 | 29449344 | |
354 | Ubiquitination | ERQILHQKETNQDVQ HHHHHHHHHCCCCCC | 56.62 | - | |
383 | Phosphorylation | CILNGINSSAKKNSN EEECCCCCCCCCCCC | 29.74 | 25627689 | |
384 | Phosphorylation | ILNGINSSAKKNSNW EECCCCCCCCCCCCC | 39.35 | 28555341 | |
393 | Acetylation | KKNSNWTKIKLSKFN CCCCCCCEEEHHHCC | 29.47 | 26051181 | |
398 | Ubiquitination | WTKIKLSKFNSVQHN CCEEEHHHCCCCCCC | 60.03 | - | |
406 | Ubiquitination | FNSVQHNKLDSQVSP CCCCCCCCCCCCCCC | 52.09 | - | |
409 | Phosphorylation | VQHNKLDSQVSPKLG CCCCCCCCCCCCCCC | 42.81 | 20068231 | |
412 | Phosphorylation | NKLDSQVSPKLGLLR CCCCCCCCCCCCCCC | 14.53 | 30278072 | |
423 | Phosphorylation | GLLRTSFSPPALEMH CCCCCCCCCCCCCCC | 29.73 | 25159151 | |
469 | Phosphorylation | EVKINDITVEINKTT CEEECEEEEEEECCC | 18.23 | 24114839 | |
513 | Phosphorylation | SASNKNFSQCLESKL HCCCCCHHHHHHHHH | 29.40 | 26714015 | |
523 | Phosphorylation | LESKLENSPVENVTA HHHHHHCCCCCCHHH | 22.43 | 29255136 | |
529 | Phosphorylation | NSPVENVTAASTLLS CCCCCCHHHHHHHHH | 28.25 | 29978859 | |
546 | Acetylation | KIDTGENKFPGSAPQ CCCCCCCCCCCCCHH | 48.94 | 26051181 | |
582 | Phosphorylation | HSLPKCNSHLEITIP CCCCCCCCCEEEECC | 38.63 | 28348404 | |
590 | Acetylation | HLEITIPKDLKLKEA CEEEECCCCCCCCCC | 72.36 | 25953088 | |
612 | Acetylation | LIIDAGQKRFGAVSC EEEECCHHHCCEEEE | 49.10 | 25953088 | |
706 | Phosphorylation | PLMCYSRTKTLLFIS CEEEECCCCEEEEEC | 23.57 | - | |
747 | Acetylation | VIRSEEEKVRFERQK CCCCHHHHHHHHHHH | 41.83 | 25953088 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ESCO1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ESCO1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ESCO1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. |